Euphrates Vascular, Inc.

Biotechnology company · St. Louis, Missouri, United States

Euphrates Vascular, Inc. is a biotechnology company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $9.1 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Euphrates Vascular at a glance

Typebiotechnology company

HeadquartersSt. Louis, Missouri, United States

Earliest incorporation on record2018

SEC CIK1752992

What does Euphrates Vascular do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $9.1 million sold (2023).

Frequently asked questions about Euphrates Vascular

Where is Euphrates Vascular headquartered?

Euphrates Vascular, Inc. is headquartered in St. Louis, Missouri, United States.

What does Euphrates Vascular do?

Euphrates Vascular, Inc. is a biotechnology company.

When was Euphrates Vascular founded?

The earliest incorporation on record for Euphrates Vascular, Inc. is in 2018, according to public company registers.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences